cystine has been researched along with n,n-diacetylcystine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bässler, KH; Böhler, S; Neuhäuser-Berthold, M; Virmani, K; Wagner, K | 1 |
| Bergstrand, H; Jansson, AH; Matuseviciene, G; Pierrou, S; Särnstrand, B; Scheynius, A | 1 |
| Andersson, T; Boräng, S; Larsson, M; Lundeberg, J; Odeberg, J; Thelin, A | 1 |
| Bergstrand, H; Jansson, AH; Ostlund-Lindqvist, AM; Pettersson, K; Särnstrand, B; Wågberg, M; Westerlund, C | 1 |
| Doggrell, SA | 1 |
| Bergstrand, H; Pettersson, K | 1 |
| Lin, Y; Ren, XC; Wang, P; Wu, XM; Yu, J | 1 |
| Johansson, K; Jungersten, L; Kalies, I; Kjerrulf, M; Långström, G; Lenkei, R; Lind, L; Pettersson, K; Walldius, G | 1 |
| Abrahamsson, T; Carrier, M; Eliasson, UB; Kengatharan, KM; Pettersson, KS; Wågberg, M | 1 |
| Adamo, V; Bonnabry, P; Bouchoud, L; Sadeghipour, F; Schwebel, H; Sommer, I | 1 |
| Kim, D; Ku, DN; Shea, SM | 1 |
1 review(s) available for cystine and n,n-diacetylcystine
| Article | Year |
|---|---|
The antiatherogenic effect of DiNAC: experimental findings supporting immunomodulation as a new treatment for atherosclerosis related diseases.
Topics: Adjuvants, Immunologic; Animals; Antioxidants; Arteriosclerosis; Clinical Trials as Topic; Cystine; Drug Evaluation, Preclinical; Endothelium, Vascular; Humans; Hypersensitivity, Delayed; Quantitative Structure-Activity Relationship; Vasodilation | 2003 |
1 trial(s) available for cystine and n,n-diacetylcystine
| Article | Year |
|---|---|
The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism.
Topics: Acetylcysteine; Aged; Brachial Artery; Cells, Cultured; Cystine; Dose-Response Relationship, Drug; Double-Blind Method; Endothelial Cells; Female; Humans; Hypercholesterolemia; Hyperemia; Immunologic Factors; Leukocytes; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Postmenopause; Ultrasonography; Umbilical Veins; Vasodilation; Vasodilator Agents | 2008 |
9 other study(ies) available for cystine and n,n-diacetylcystine
| Article | Year |
|---|---|
[Cysteine in parenteral nutrition: comparative study of N-acetyl-cysteine and N,N-diacetylcystine in the rat model].
Topics: Acetylcysteine; Animals; Cysteine; Cystine; Liver; Male; Parenteral Nutrition, Total; Rats; Rats, Inbred Strains | 1988 |
N,N'-Diacetyl-L-cystine-the disulfide dimer of N-acetylcysteine-is a potent modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents.
Topics: Acetylcysteine; Adjuvants, Immunologic; Animals; CD8-Positive T-Lymphocytes; Cystine; Dermatitis, Contact; Dinitrofluorobenzene; Ear; Female; Fluorescein-5-isothiocyanate; Foot; Granuloma; Hypersensitivity, Delayed; Immunohistochemistry; Lymphocyte Count; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Oxazolone; Rabbits; Serum Albumin, Bovine | 1999 |
Monitoring of the subtraction process in solid-phase representational difference analysis: characterization of a candidate drug.
Topics: Arteriosclerosis; Cell Line; Cystine; DNA, Complementary; Gene Expression Profiling; Gene Expression Regulation; Humans; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Software | 2001 |
N,N'-diacetyl-L-cystine (DiNAC), the disulphide dimer of N-acetylcysteine, inhibits atherosclerosis in WHHL rabbits: evidence for immunomodulatory agents as a new approach to prevent atherosclerosis.
Topics: Acetylcysteine; Adjuvants, Immunologic; Animals; Antioxidants; Arteriosclerosis; Cholesterol; Cystine; Dermatitis, Contact; Disulfides; Male; Mice; Mice, Inbred BALB C; Oxazolone; Probucol; Rabbits; Receptors, LDL; Structure-Activity Relationship; Triglycerides | 2001 |
Immunomodulation with DiNAC-- a new approach to the treatment of atherosclerosis?
Topics: Adjuvants, Immunologic; Animals; Arteriosclerosis; Benzhydryl Compounds; Cystine; Dermatitis, Contact; Mice; Mice, Inbred BALB C; Phenols; Probucol; Rabbits | 2002 |
Influence of N,N'-diacetyl-L-cystine on D-galactosamine/lipopolysaccharide induced immunological liver failure in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; CD4 Antigens; CD8 Antigens; Cell Differentiation; Cell Proliferation; Cystine; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred BALB C; T-Lymphocytes | 2004 |
N,N-diacetyl-L-cystine improves endothelial function in atherosclerotic Watanabe heritable hyperlipidaemic rabbits.
Topics: Acetylcholine; Administration, Oral; Animals; Aorta; Atherosclerosis; Cystine; Disease Models, Animal; Endothelium, Vascular; Immunologic Factors; In Vitro Techniques; Male; Pulsatile Flow; Rabbits; Vasodilation; Water Supply | 2007 |
Stability of
Topics: Acetylcysteine; Amino Acids; Biological Availability; Cysteine; Cystine; Drug Industry; Drug Stability; Drug Storage; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Premature; Nutritional Requirements; Oxidation-Reduction; Oxygen; Parenteral Nutrition; Parenteral Nutrition Solutions | 2020 |
Lysis of arterial thrombi by perfusion of N,N'-Diacetyl-L-cystine (DiNAC).
Topics: Animals; Cystine; Fibrinolytic Agents; Swine; Thrombolytic Therapy; Thrombosis; Thrombotic Stroke | 2021 |